Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04689022
Other study ID # BogomoletsNMU
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2014
Est. completion date October 1, 2020

Study information

Verified date December 2020
Source Bogomolets National Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The 82.1% treatment failure of post-traumatic stress disorder(PTSD), associated with gunshot wounds, is related to high incidence of chronic pain syndrome as well as resistance to the PTSD treatment. Defining treatment failure predictors among the PTSD patients with gunshot extremity wounds and the following therapy would improve treatment outcomes.


Description:

It has been noted that the PTSD in military combatants results from their direct participation in military actions. The study revealed that if a military combatant was wounded during the action operation, his emotional and subjective feelings will 100% lead to the PTSD. Other scientists state about the PTSD remote treatment failure in 80% of the military combatants. The study evidences about 82.1% of the PTSD m-related wounds treatment failure, which was essential for the subsequent studies. Some authors state about treatment effectiveness of psychopharmacological drugs and psychotherapy, which is rather questionable. Traumas and somatic diseases in the PTSD patients are known to accumulate their negative effects. So, definition of the PTSD treatment failure predictors may improve treatment outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 218
Est. completion date October 1, 2020
Est. primary completion date December 30, 2019
Accepts healthy volunteers No
Gender Male
Age group N/A and older
Eligibility Inclusion Criteria: - gunshot wounds - post-traumatic stress disorder - patients who need anesthesia Exclusion Criteria: - the patient has no post-traumatic stress disorder - the patient has no gunshot wounds

Study Design


Intervention

Behavioral:
Mississippi Scale for Combat-Related PTSD (M-PTSD)
The treatment outcome rate was assessed by the Mississippi Scale for Combat-Related PTSD (M-PTSD). A positive outcome rate is represented with the patient post-discharge positive coping, which corresponds to 94-58 points, observed in 39 patients (17.9%). A treatment failure is regarded as the absent PTSD treatment effect after discharge, which corresponds to 148-113 points, observed in 5 patients (2.3%) and psychic disorders, which correspond to 112-95 points, observed in 174 patients (79,8%).
Diagnostic Test:
visual analogue scale (VAS)
pain intensity
Douleur Neuropathique 4 questions (DN4)
neuropathic pain component

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Vasyl' Horoshko Bogomolets National Medical University

Outcome

Type Measure Description Time frame Safety issue
Primary Mississippi Scale for Combat-Related PTSD (M-PTSD) The treatment outcome rate was assessed by the Mississippi Scale for Combat-Related PTSD (M-PTSD). A positive outcome rate is represented with the patient post-discharge positive coping, which corresponds to 94-58 points. A treatment failure is regarded as the absent PTSD treatment effect after discharge, which corresponds to 148-113 points and psychic disorders, which correspond to 112-95 points. 1 year